Neuropathic Pain Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Jun 2020| TMR2049A| Transparency

Report Highlights

Neuropathic Pain Therapeutics Market – Scope of the Report

TMR’s report on the global neuropathic pain therapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global neuropathic pain therapeutics market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global neuropathic pain therapeutics market from 2020 to 2030.

The report has been prepared after extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global neuropathic pain therapeutics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various attributes of the global neuropathic pain therapeutics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global neuropathic pain therapeutics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global neuropathic pain therapeutics market.

The report also delves into the competition landscape of the global neuropathic pain therapeutics market. Key players operating in the global neuropathic pain therapeutics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global neuropathic pain therapeutics market that have been profiled in this report.

Key Questions Answered in Neuropathic Pain Therapeutics Market Report

What is the sales/revenue generated by neuropathic pain drugs across all regions during the forecast period?
What are the opportunities in the global neuropathic therapeutics pain market?
What are the major drivers, restraints, opportunities, and threats in the global market?
Which region is set to expand at the fastest CAGR during the forecast period?
Which indication segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Neuropathic Pain Therapeutics Market – Research Objectives and Research Approach

The comprehensive report on the global neuropathic pain therapeutics market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global neuropathic pain therapeutics market in terms of drug class, disease type, distribution channel, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. Such valuable insights enable market stakeholders to make informed business decisions for investment in the global neuropathic pain therapeutics market.

  • Table 1 : Global Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
  • Table 2 : Global Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Antidepressants, 2018-2030
  • Table 3 : Global Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2018-2030
  • Table 4 : Global Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 5 : Global Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 6 : Global Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Region, 2018-2030
  • Table 7 : North America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
  • Table 8 : North America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Antidepressants, 2018-2030
  • Table 9 : North America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2018-2030
  • Table 10 : North America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 11 : North America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 12 : North America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Country, 2018-2030
  • Table 13 : Europe Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
  • Table 14 : Europe Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Antidepressants, 2018-2030
  • Table 15 : Europe Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2018-2030
  • Table 16 : Europe Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 17 : Europe Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 18 : Europe Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 19 : Asia Pacific Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
  • Table 20 : Asia Pacific Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Antidepressants, 2018-2030
  • Table 21 : Asia Pacific Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2018-2030
  • Table 22 : Asia Pacific Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 23 : Asia Pacific Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 24 : Asia Pacific Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 25 : Latin America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
  • Table 26 : Latin America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Antidepressants, 2018-2030
  • Table 27 : Latin America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2018-2030
  • Table 28 : Latin America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 29 : Latin America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 30 : Latin America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 31 : Middle East & Africa Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
  • Table 32 : Middle East & Africa Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Antidepressants, 2018-2030
  • Table 33 : Middle East & Africa Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2018-2030
  • Table 34 : Middle East & Africa Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 35 : Middle East & Africa Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 36 : Middle East & Africa Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Figure 1 : Global Neuropathic Pain Therapeutics Market Value (US$ Mn) and Distribution (%), by Region, 2019 and 2030
  • Figure 2 : Global Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 3 : Market Value Share, by Drug Class, 2019
  • Figure 4 : Market Value Share, by Disease Type, 2019
  • Figure 5 : Market Value Share, by Route of Administration, 2019
  • Figure 6 : Market Value Share, by Distribution Channel, 2019
  • Figure 7 : Global Neuropathic Pain Therapeutics Market Value Share Analysis, by Drug Class, 2019 and 2030
  • Figure 8 : Global Neuropathic Pain Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Anticonvulsants, 2018-2020
  • Figure 9 : Global Neuropathic Pain Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Antidepressants, 2018-2020
  • Figure 10 : Global Neuropathic Pain Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by NSAIDs, 2018-2020
  • Figure 11 : Global Neuropathic Pain Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Opioids, 2018-2020
  • Figure 12 : Global Neuropathic Pain Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Steroids, 2018-2020
  • Figure 13 : Global Neuropathic Pain Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2018-2020
  • Figure 14 : Global Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2020-2030
  • Figure 15 : Global Neuropathic Pain Therapeutics Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 16 : Global Neuropathic Pain Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diabetic Neuropathy, 2018-2020
  • Figure 17 : Global Neuropathic Pain Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Post-herpetic Neuralgia, 2018-2020
  • Figure 18 : Global Neuropathic Pain Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer-related Pain, 2018-2020
  • Figure 19 : Global Neuropathic Pain Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Spinal Cord Injury, 2018-2020
  • Figure 20 : Global Neuropathic Pain Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2018-2020
  • Figure 21 : Global Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 22 : Global Neuropathic Pain Therapeutics Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 23 : Global Neuropathic Pain Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oral, 2018-2020
  • Figure 24 : Global Neuropathic Pain Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Topical, 2018-2020
  • Figure 25 : Global Neuropathic Pain Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2018-2020
  • Figure 26 : Global Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 27 : Global Neuropathic Pain Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 28 : Global Neuropathic Pain Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2018-2030
  • Figure 29 : Global Neuropathic Pain Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2018-2030
  • Figure 30 : Global Neuropathic Pain Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2018-2030
  • Figure 31 : Global Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 32 : Global Neuropathic Pain Therapeutics Market, by Region, 2019 and 2030
  • Figure 33 : Global Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Region, 2020-2030
  • Figure 34 : North America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 35 : North America Neuropathic Pain Therapeutics Market Value Share Analysis, by Drug Class, 2019 and 2030
  • Figure 36 : North America Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2020-2030
  • Figure 37 : North America Neuropathic Pain Therapeutics Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 38 : North America Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 39 : North America Neuropathic Pain Therapeutics Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 40 : North America Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 41 : North America Neuropathic Pain Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 42 : North America Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 43 : North America Neuropathic Pain Therapeutics Market Value Share Analysis, by Country, 2019 and 2030
  • Figure 44 : North America Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Country, 2020-2030
  • Figure 45 : Europe Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 46 : Europe Neuropathic Pain Therapeutics Market Value Share Analysis, by Drug Class, 2019 and 2030
  • Figure 47 : Europe Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2020-2030
  • Figure 48 : Europe Neuropathic Pain Therapeutics Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 49 : Europe Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 50 : Europe Neuropathic Pain Therapeutics Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 51 : Europe Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 52 : Europe Neuropathic Pain Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 53 : Europe Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 54 : Europe Neuropathic Pain Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 55 : Europe Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 56 : Asia Pacific Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 57 : Asia Pacific Neuropathic Pain Therapeutics Market Value Share Analysis, by Drug Class, 2019 and 2030
  • Figure 58 : Asia Pacific Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2020-2030
  • Figure 59 : Asia Pacific Neuropathic Pain Therapeutics Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 60 : Asia Pacific Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 61 : Asia Pacific Neuropathic Pain Therapeutics Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 62 : Asia Pacific Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 63 : Asia Pacific Neuropathic Pain Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 64 : Asia Pacific Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 65 : Asia Pacific Neuropathic Pain Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 66 : Asia Pacific Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 67 : Latin America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 68 : Latin America Neuropathic Pain Therapeutics Market Value Share Analysis, by Drug Class, 2019 and 2030
  • Figure 69 : Latin America Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2020-2030
  • Figure 70 : Latin America Neuropathic Pain Therapeutics Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 71 : Latin America Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 72 : Latin America Neuropathic Pain Therapeutics Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 73 : Latin America Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 74 : Latin America Neuropathic Pain Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 75 : Latin America Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 76 : Latin America Neuropathic Pain Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 77 : Latin America Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 78 : Middle East & Africa Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 79 : Middle East & Africa Neuropathic Pain Therapeutics Market Value Share Analysis, by Drug Class, 2019 and 2030
  • Figure 80 : Middle East & Africa Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2020-2030
  • Figure 81 : Middle East & Africa Neuropathic Pain Therapeutics Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 82 : Middle East & Africa Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 83 : Middle East & Africa Neuropathic Pain Therapeutics Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 84 : Middle East & Africa Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 85 : Middle East & Africa Neuropathic Pain Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 86 : Middle East & Africa Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 87 : Middle East & Africa Neuropathic Pain Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 88 : Middle East & Africa Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020-2030

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report